Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > SBM could double in a heartbeat
View:
Post by tylerreddick on Sep 30, 2024 8:02am

SBM could double in a heartbeat

" We are in active discussions with investment funds to support our financial needs, and the approaching commercialization of our products has generated increased interest. We plan to provide a financing update shortly "

If that is actually accurate, securing a financing attached to their planned timeline for GPM, that could double the share price in a heartbeat.

Everyone, including me, is worried that this company could go belly up. Putting that worry to bed, and looking ahead to actual profitability, chnages everything.
Comment by sakinny3 on Sep 30, 2024 8:53am
The problem is, if the last interview is a view into our ability to articulate the companies products and goals, we are in trouble trying to persuade someone to give us money.
Comment by tylerreddick on Sep 30, 2024 9:05am
Any potential backer will do it because of the science, not Howie's "personality" and "spiffy" dress code.
Comment by forhandlaren on Sep 30, 2024 1:14pm
I agree. Just had another view. The interview is nothing short of a disaster. The host shake her head while Howard read his script! Maybe a third party can step in and represent the company in negotiations.
Comment by PeterG on Sep 30, 2024 2:04pm
But coming back to the interview: why has Howard doing it? Was there no time for preparation? Was the content not clear? 4 minutes, not more and the CEO is muddled in every sentence? Come on!! If he wants to attract the company for other investors, I'll exoect at least a bit of professionalism.
Comment by Pandora on Sep 30, 2024 3:01pm
I believe SBM has financials posted on Sedar -- if anyone can navigate that system and verify it?
Comment by sakinny3 on Sep 30, 2024 3:53pm
They are also posted on the company website
Comment by Pandora on Sep 30, 2024 4:14pm
I see Q3 (End of July) on the website. I see this on StockWatch which I assume does not reflect End of July, but I could be wrong. 2024-09-30 12:05 C:SBM Sirona Biochem Corp 0.085 SEDAR Interim Financial Statements SEDAR Interim Financial Statements 2024-09-30 12:05 C:SBM Sirona Biochem Corp 0.085  ...more  
Comment by Pandora on Sep 30, 2024 4:20pm
I guess it could reflect end of July after all -- now that I look a little further back on Stockwatch headlines: Date ET Symbol Price Type Headline 2024-09-30 12:05 C:SBM 0.085 SEDAR Interim Financial Statements SEDAR Interim Financial Statements 2024-09-30 12:05 C:SBM 0 ...more  
Comment by Pandora on Sep 30, 2024 4:24pm
And their opening statement on the financials posted on the website. I definitely stand corrected! My apologies! 1 SIRONA BIOCHEM CORP. (A Development Stage Company) MANAGEMENT’S DISCUSSION AND ANALYSIS FOR THE NINE MONTHS ENDED JULY 31, 2024 ITEM 1.1 INTRODUCTION The following Management Discussion and Analysis (“MD&A”) was prepared as of September 30, 2024 and should be read in conjunction ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities